The Wei et.al find that the inhibition of lncRNA AL590705.3 expression decreased the proliferative capacity of HCC cells but enhanced FDX1 expression.[34] AL590705.3 may affect HCC progression by participating in the occurrence of cuproptosis. The gene discussed is FDX1; the disease is hepatocellular carcinoma.